Blog archive

Cyber threats are here to stay. Mills & Reeve's new report, Defensive Lines, provides a useful benchmark to take stock of an organisation's own preparation and response practices and procedures.

The UK's Genetic Technology Act offers a new approach to the assessment and approval of innovative agrifood technologies that deploy precision breeding.

We look at new draft guidance on how competition law applies to environmental sustainability agreements between businesses, and how this applies in the life sciences sector.

We take a look at what the Windsor Framework means for the life sciences sector.

Making medicines available to those in low or middle income countries is an ongoing challenge. What is the contribution of the Medicines Patent Pool to addressing that problem?

UK medical devices regulator, the MHRA, is planning a 12-month extension to its planned reforms of the regulatory system, and a new approach to provide effective and proportionate regulation for the growing software and AI medical device sectors. What can business expect?

A patent application relating to an app to support patient compliance with a medicine dosing regime did not meet the European Patent Office requirements for protection.

We look at a new visa route for fast and high growth companies seeking to hire skilled people from around the world.

We review progress on the UK Government consultation on the regulation of medical devices, and look at the shape and timing of forthcoming reforms.

We look at some recent examples of enforcement of advertising rules in the life sciences sector in the context of online promotional activity.

The ABPI is proposing a new set of principles to improve public trust and transparency around the use of health data.

We look at the Good Machine Learning Practice guidance for medical devices drawn up jointly by regulators in the US, Canada and the UK.